All these findings support that RETNLB might be a valuable prognostic biomarker in oral squamous cell carcinoma patients, and implying that further exploration of RETNLB’s role in oral squamous cell carcinoma is necessary. This evidence concerns the gene RETNLB and oral cavity squamous cell carcinoma.